The global market for spinal fusion, which includes spinal plating systems, interbody devices, vertebral body replacement devices, and pedicle screw systems (excluding minimally invasive spine devices), is estimated to rise from around $7.1 billion in 2016 to just under $9 billion by 2023, rendering a combined annual increase rate of 3.4%, according to GlobalData. In the western economies, spinal fusion is one of the top ten procedures that most payers are looking at the rate of increased utilization, aggregate spending and the likelihood of continued increases based on demographics.

The constant market growth includes 39 countries, will primarily be driven by the growing prevalence of degenerative spinal conditions due to aging, continued technological advancements in spinal fusion surgeries, such as expendable interbody cages and navigation systems, and the increased adoption of minimally invasive techniques.

The huge success in adopting of new technology and methodology in recent years drive the global market at the faster growth rate. Fusion surgery has been proven to provide better clinical outcomes for spondylolisthesis patients than conservative care alone or decompression surgery alone. The excellent performance of spinal fusion in these indications will continue to drive the procedure’s adoption.

In Europe and North America, spine surgeons are afforded the autonomy to perform the procedure in the indications that they see fit. IN Europe, the adaptability of surgeons to perform the procedure in a multitude of indications with minimal intervention will continue to boost the European spinal fusion market.